Validations: Process Drifts, Impact & Controls

Cell Culture Variability: Inoculum, Feeds, and DO/pH

<!– –> Cell Culture Variability: Inoculum, Feeds, and DO/pH Cell Culture Variability: Inoculum, Feeds, and DO/pH In the biotechnology and pharmaceutical sectors, ensuring the quality and comparability of biosimilars is crucial for meeting regulatory demands and maintaining patient safety. A critical aspect of this is understanding cell culture variability, particularly related to inoculum preparation, feed strategies, and the management of…

Continue Reading Cell Culture Variability: Inoculum, Feeds, and DO/pH

Downstream Robustness: Load, Wash, and Elution Windows

Downstream Robustness: Load, Wash, and Elution Windows Downstream Robustness: Load, Wash, and Elution Windows The successful development and commercialization of biosimilars hinge on robust processes that ensure analytical comparability with reference products. This tutorial focuses on the downstream robustness of biosimilar production, particularly the importance of establishing and managing load, wash, and elution windows. We will navigate comprehensive methodologies, best…

Continue Reading Downstream Robustness: Load, Wash, and Elution Windows

Process Drift Signals: From CPP Movements to CQA Shifts

Process Drift Signals: From CPP Movements to CQA Shifts Process Drift Signals: From CPP Movements to CQA Shifts The realm of biosimilars is intricate and mandates a comprehensive understanding of analytical comparability, particularly when it comes to monitoring process drift signals. This tutorial will provide a structured approach to navigating these concepts, focusing on CQA mapping, fingerprint analytics, and the…

Continue Reading Process Drift Signals: From CPP Movements to CQA Shifts

Trend Designs: Control Charts, EWMA, and Multivariate MSPC

Trend Designs: Control Charts, EWMA, and Multivariate MSPC Trend Designs: Control Charts, EWMA, and Multivariate MSPC Introduction to Biosimilar Analytical Comparability In the realm of biopharmaceuticals, establishing biosimilar analytical comparability is a fundamental regulatory requirement mandated by authorities including the FDA, EMA, and MHRA. The goal of analytical comparability is to demonstrate that the biosimilar is highly similar to its…

Continue Reading Trend Designs: Control Charts, EWMA, and Multivariate MSPC

Raw Material Variability: Detecting and Damping the Impact

Raw Material Variability: Detecting and Damping the Impact Raw Material Variability: Detecting and Damping the Impact In the continuously evolving field of biotechnology, ensuring biosimilar products’ safety, efficacy, and quality is paramount. A critical component of this assurance lies in the careful evaluation of raw material variability. This article provides a comprehensive step-by-step tutorial on detecting and damping the impact…

Continue Reading Raw Material Variability: Detecting and Damping the Impact